Concord Capital Stock vs Net Receivables Analysis
CCM Stock | USD 0.59 0.09 18.00% |
Concord Medical financial indicator trend analysis is way more than just evaluating Concord Medical Services prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Concord Medical Services is a good investment. Please check the relationship between Concord Medical Capital Stock and its Net Receivables accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Capital Stock vs Net Receivables
Capital Stock vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Concord Medical Services Capital Stock account and Net Receivables. At this time, the significance of the direction appears to have strong relationship.
The correlation between Concord Medical's Capital Stock and Net Receivables is 0.61. Overlapping area represents the amount of variation of Capital Stock that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Concord Medical Services, assuming nothing else is changed. The correlation between historical values of Concord Medical's Capital Stock and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Stock of Concord Medical Services are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Capital Stock i.e., Concord Medical's Capital Stock and Net Receivables go up and down completely randomly.
Correlation Coefficient | 0.61 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Capital Stock
The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.Net Receivables
Most indicators from Concord Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Concord Medical Services current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. As of the 29th of April 2024, Enterprise Value is likely to grow to about 3.8 B, while Selling General Administrative is likely to drop about 186.8 M.
Concord Medical fundamental ratios Correlations
Click cells to compare fundamentals
Concord Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Concord Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.6B | 4.3B | 5.3B | 6.0B | 6.1B | 4.0B | |
Other Current Liab | 400.7M | 274.7M | 243.2M | 325.2M | 674.1M | 707.8M | |
Total Current Liabilities | 870.3M | 627.5M | 512.1M | 1.1B | 2.0B | 2.0B | |
Total Stockholder Equity | 437.4M | (122.8M) | (663.0M) | (1.9B) | (2.1B) | (2.0B) | |
Other Liab | 287.0M | 270.2M | 230.1M | 268.9M | 309.2M | 324.7M | |
Cash | 404.7M | 74.3M | 334.3M | 158.3M | 58.1M | 55.2M | |
Other Assets | 661.1M | 409.9M | 250.6M | 24.0M | 27.6M | 26.2M | |
Long Term Debt | 1.3B | 2.0B | 2.2B | 2.5B | 2.0B | 2.1B | |
Good Will | 165.2M | 210.4M | 213.7M | 575.4M | 661.7M | 694.8M | |
Common Stock Shares Outstanding | 43.4M | 43.4M | 43.4M | 43.7M | 50.2M | 47.0M | |
Other Current Assets | 5.1M | 4.3M | 31.4M | 24.3M | 412.9M | 433.6M | |
Total Liab | 2.3B | 2.4B | 2.9B | 4.0B | 4.3B | 4.5B | |
Intangible Assets | 895.2M | 532.5M | 522.8M | 762.1M | 721.1M | 425.8M | |
Property Plant Equipment | 2.5B | 3.2B | 3.8B | 3.9B | 4.4B | 4.7B | |
Short Long Term Debt Total | 938.1M | 1.9B | 2.4B | 3.2B | 3.3B | 3.5B | |
Property Plant And Equipment Net | 1.2B | 2.5B | 3.2B | 3.4B | 3.7B | 3.9B | |
Current Deferred Revenue | 23.6M | 3.2M | 87.7M | 100.8M | 59.4M | 32.8M | |
Net Debt | 533.4M | 1.8B | 2.0B | 3.1B | 3.2B | 3.4B | |
Retained Earnings | (1.2B) | (1.8B) | (2.5B) | (3.8B) | (4.1B) | (3.9B) | |
Accounts Payable | 5.4M | 8.3M | 18.6M | 146.7M | 129.2M | 135.7M | |
Non Current Assets Total | 3.4B | 4.0B | 4.7B | 5.2B | 5.4B | 3.2B | |
Non Currrent Assets Other | 4.9M | 661.1M | 107.5M | 23.2M | 6.3M | 6.0M | |
Cash And Short Term Investments | 454.7M | 74.3M | 334.3M | 158.3M | 58.1M | 55.2M | |
Net Receivables | 343.1M | 199.6M | 280.4M | 512.8M | 73.5M | 69.8M | |
Liabilities And Stockholders Equity | 4.6B | 4.3B | 5.3B | 6.0B | 6.1B | 4.2B | |
Non Current Liabilities Total | 1.4B | 1.8B | 2.4B | 2.9B | 2.4B | 1.3B | |
Other Stockholder Equity | 1.8B | 1.8B | 1.8B | 1.9B | 2.0B | 1.6B | |
Property Plant And Equipment Gross | 2.5B | 3.4B | 3.6B | 3.8B | 4.1B | 4.3B | |
Total Current Assets | 1.2B | 282.5M | 676.0M | 759.8M | 617.2M | 741.5M | |
Accumulated Other Comprehensive Income | (88.6M) | (97.3M) | (46.4M) | (27.8M) | (65.4M) | (62.1M) | |
Short Term Debt | 440.6M | 341.3M | 162.5M | 548.5M | 1.1B | 1.1B | |
Short Term Investments | 50M | 35.2M | 25.0M | 2.7M | 2.4M | 2.3M | |
Inventory | 3.4M | 4.3M | 21.6M | 84.8M | 40.3M | 27.4M | |
Net Tangible Assets | (865.7M) | (1.4B) | (2.6B) | (2.8B) | (2.5B) | (2.4B) | |
Long Term Investments | 64.9M | 313.0M | 390.6M | 437.9M | 394.7M | 319.4M | |
Short Long Term Debt | 328.4M | 148.9M | 299.4M | 512.6M | 1.0B | 537.8M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Concord Stock analysis
When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stocks Directory Find actively traded stocks across global markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 12.302 | Quarterly Revenue Growth (0.23) | Return On Assets (0.05) | Return On Equity (0.28) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.